Cargando…

Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions

Cystic papillary thyroid carcinoma (cPTC) is a subgroup of PTC presenting a diagnostic challenge at fine needle aspiration biopsy (FNAB). To further investigate this entity we aimed to characterize protein profiles of cyst fluids from cPTC and benign thyroid cystic lesions. In total, 20 cPTCs and 56...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dinets, Andrii, Pernemalm, Maria, Kjellin, Hanna, Sviatoha, Vitalijs, Sofiadis, Anastasios, Juhlin, C. Christofer, Zedenius, Jan, Larsson, Catharina, Lehtiö, Janne, Höög, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433121/ https://www.ncbi.nlm.nih.gov/pubmed/25978681 http://dx.doi.org/10.1371/journal.pone.0126472

Ejemplares similares

Proteomic profiling of follicular and papillary thyroid tumors
por: Sofiadis, Anastasios, et al.
Publicado: (2012)

Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma
por: Dinets, Andrii, et al.
Publicado: (2012)

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma
por: Wang, Na, et al.
Publicado: (2016)

High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma
por: Mu, Ninni, et al.
Publicado: (2018)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

Telomerase-Dependent and Independent Telomere Maintenance and its Clinical Implications in Medullary Thyroid Carcinoma
por: Wang, Na, et al.
Publicado: (2014)

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
por: Hellgren, L. Samuel, et al.
Publicado: (2022)

Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?
por: Juhlin, C. Christofer, et al.
Publicado: (2022)

Minimally invasive follicular thyroid carcinomas: prognostic factors
por: Stenson, Gustav, et al.
Publicado: (2016)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman – a case report
por: Paulsson, Johan O., et al.
Publicado: (2018)

Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature
por: Stenman, Adam, et al.
Publicado: (2022)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
por: Johansson, Klara, et al.
Publicado: (2021)

Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma
por: Stenman, Adam, et al.
Publicado: (2021)

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
por: Fotouhi, Omid, et al.
Publicado: (2016)

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
por: Hysek, Martin, et al.
Publicado: (2019)

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

Differentially Expressed Proteins in Malignant and Benign Adrenocortical Tumors
por: Kjellin, Hanna, et al.
Publicado: (2014)

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
por: Xing, Xiangling, et al.
Publicado: (2020)

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours
por: Paulsson, Johan O, et al.
Publicado: (2020)

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
por: Hellgren, L Samuel, et al.
Publicado: (2022)

Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics
por: Hysek, Martin, et al.
Publicado: (2019)

TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression
por: Paulsson, Johan O., et al.
Publicado: (2021)

Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
por: Juhlin, Carl Christofer, et al.
Publicado: (2020)

Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
por: Juhlin, Carl Christofer, et al.
Publicado: (2022)

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight
por: Haglund, Felix, et al.
Publicado: (2015)

Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer
por: Nilsson, Joachim N., et al.
Publicado: (2023)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
por: Nilsson, Joachim N, et al.
Publicado: (2023)

PSAT286 A Rare Case of Papillary Thyroid Cancer of the Thyroglossal Duct Cyst with Benign Thyroid
por: Shakir, Nabeela, et al.
Publicado: (2022)

Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature
por: Hellgren, L. Samuel, et al.
Publicado: (2020)

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index
por: Nilsson, Joachim N., et al.
Publicado: (2021)

Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma
por: Stenman, Adam, et al.
Publicado: (2021)

Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma
por: Bo, Xiao-Wan, et al.
Publicado: (2020)

Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years
por: Juhlin, C. Christofer, et al.
Publicado: (2020)

Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8
por: Paulsson, Johan O, et al.
Publicado: (2021)

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features
por: Xing, Xiangling, et al.
Publicado: (2022)

Parathyroid Adenoma With Respiratory-Like Epithelium: Case Report of a Potential Mimic With Unknown Etiology
por: Juhlin, C. Christofer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_26qjc3m4nbskbt50edreevgrj8